Thursday, October 15, 2026
Thursday, October 15, 2026
Klebsiella pneumoniae poses a growing global threat due to rising multidrug resistance and hypervirulence. This talk reviews current vaccine approaches—including glycoconjugates, protein antigens, and OMVs—alongside key translation challenges like antigenic diversity and preclinical models.